Glass Lewis & Co. recommended on Aug. 13 that its shareholders vote for the proposed deal. Glass Lewis & Co. is the second proxy advisory firm to support the pending transaction after Institutional Shareholder Services backed the deal on Aug. 10. Hedge fund Glenview Capital Management, which has stake in Cigna, also backed the potential deal.
Glass Lewis said the merger would be strategically and financially advantageous for Cigna shareholders, according to the report. Shareholders are set to vote on the deal Aug. 24.
More articles on payers:
8 recent payer-provider disputes, resolutions
Humana divests $2.4B long-term insurance business
Risk adjustment payments to be based on 2018 premiums, CMS proposes
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
